A population pharmacokinetic-pharmacodynamic model for tenofovir in plasma and rectal tissues of healthy volunteers

被引：0
|
作者：
Jayachandran, P. [1 ]
Garcia-Cremades, M. [1 ]
Anton, P. [3 ]
Hendrix, C. [2 ]
Savic, R. M. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] Johns Hopkins Univ, Dept Med, Div Clin Pharmacol, Baltimore, MD USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-012
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [41] Population pharmacokinetic/pharmacodynamic modelling of nifekalant in healthy Chinese volunteers
    Zhang, Jiashan
    Zan, Ying
    Huo, Hua
    Liu, Yanfang
    Tang, Yunbiao
    Han, Yaling
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 151
  • [42] Population pharmacokinetic-pharmacodynamic modeling of TF-505 using extension of indirect response model by incorporating a circadian rhythm in healthy volunteers
    Matsumoto, Y
    Fujita, T
    Ishida, Y
    Shimizu, M
    Kakuo, H
    Yamashita, K
    Majima, M
    Kumagai, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (08) : 1455 - 1461
  • [43] Population pharmacokinetic-pharmacodynamic analysis of givinostat
    Fiorentini, Francesco
    Germani, Massimiliano
    Del Bene, Francesca
    Pellizzoni, Cinzia
    Cazzaniga, Sara
    Rocchetti, Maurizio
    Bettica, Paolo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (04) : 229 - 238
  • [44] Pharmacokinetic-pharmacodynamic model relating zabiciprilat plasma concentrations to brachial and femoral haemodynamic effects in normotensive volunteers
    Bellissant, E
    Giudicelli, JF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (04) : 383 - 393
  • [45] Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers
    Yassen, Ashraf
    Olofsen, Erik
    Romberg, Raymonda
    Sarton, Elise
    Danhof, Meindert
    Dahan, Albert
    ANESTHESIOLOGY, 2006, 104 (06) : 1232 - 1242
  • [46] Comparison of the Pharmacokinetic-Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers
    Kim, Seokuee
    Hong, Taegon
    Ko, Jae-Wook
    Huh, Wooseong
    Kim, Jung-Ryul
    BIODRUGS, 2019, 33 (01) : 101 - 112
  • [47] Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models
    Siripuram, Vijay K.
    Wright, Daniel F. B.
    Barclay, Murray L.
    Duffull, Stephen B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (05) : 415 - 423
  • [48] Population pharmacokinetic-pharmacodynamic modelling of metoprolol with regard to cyp2d6 genotypes in healthy korean volunteers
    Oh, W. Y.
    Jung, E.
    Ryu, S.
    Jeong, S.
    Kim, K.
    Chung, J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S83 - S83
  • [49] Population pharmacokinetic-pharmacodynamic modeling of omecamtiv mecarbil, a cardiac myosin activator, in healthy volunteers and patients with stable heart failure
    Thuy Vu
    Ma, Peiming
    Xiao, Jim J.
    Wang, Yow-Ming C.
    Malik, Fady I.
    Chow, Andrew T.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (11): : 1236 - 1247
  • [50] Population Pharmacokinetic and Pharmacodynamic Analysis of Polmacoxib in Healthy Volunteers and Patients With Osteoarthritis
    Cho, Yong-Soon
    Bae, Kyun-Seop
    Choi, Seung Chan
    Cho, Joong Myung
    Lim, Hyeong-Seok
    CLINICAL THERAPEUTICS, 2022, 44 (01) : 67 - +
12345